500 related articles for article (PubMed ID: 9261125)
1. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
[TBL] [Abstract][Full Text] [Related]
2. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.
Piek E; Moustakas A; Kurisaki A; Heldin CH; ten Dijke P
J Cell Sci; 1999 Dec; 112 ( Pt 24)():4557-68. PubMed ID: 10574705
[TBL] [Abstract][Full Text] [Related]
3. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
Cárcamo J; Weis FM; Ventura F; Wieser R; Wrana JL; Attisano L; Massagué J
Mol Cell Biol; 1994 Jun; 14(6):3810-21. PubMed ID: 8196624
[TBL] [Abstract][Full Text] [Related]
4. Expression of transforming growth factor-beta superfamily receptors in rat eyes.
Obata H; Kaji Y; Yamada H; Kato M; Tsuru T; Yamashita H
Acta Ophthalmol Scand; 1999 Apr; 77(2):151-6. PubMed ID: 10321529
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
6. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis.
Oh SP; Seki T; Goss KA; Imamura T; Yi Y; Donahoe PK; Li L; Miyazono K; ten Dijke P; Kim S; Li E
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2626-31. PubMed ID: 10716993
[TBL] [Abstract][Full Text] [Related]
7. Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers.
Stockwell BR; Schreiber SL
Curr Biol; 1998 Jun; 8(13):761-70. PubMed ID: 9651680
[TBL] [Abstract][Full Text] [Related]
8. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
Macías-Silva M; Hoodless PA; Tang SJ; Buchwald M; Wrana JL
J Biol Chem; 1998 Oct; 273(40):25628-36. PubMed ID: 9748228
[TBL] [Abstract][Full Text] [Related]
9. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5.
Nishitoh H; Ichijo H; Kimura M; Matsumoto T; Makishima F; Yamaguchi A; Yamashita H; Enomoto S; Miyazono K
J Biol Chem; 1996 Aug; 271(35):21345-52. PubMed ID: 8702914
[TBL] [Abstract][Full Text] [Related]
10. Intracellular signaling of osteogenic protein-1 through Smad5 activation.
Tamaki K; Souchelnytskyi S; Itoh S; Nakao A; Sampath K; Heldin CH; ten Dijke P
J Cell Physiol; 1998 Nov; 177(2):355-63. PubMed ID: 9766532
[TBL] [Abstract][Full Text] [Related]
11. Heteromeric and homomeric transforming growth factor-beta receptors show distinct signaling and endocytic responses in epithelial cells.
Doré JJ; Edens M; Garamszegi N; Leof EB
J Biol Chem; 1998 Nov; 273(48):31770-7. PubMed ID: 9822641
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
13. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts.
Namiki M; Akiyama S; Katagiri T; Suzuki A; Ueno N; Yamaji N; Rosen V; Wozney JM; Suda T
J Biol Chem; 1997 Aug; 272(35):22046-52. PubMed ID: 9268344
[TBL] [Abstract][Full Text] [Related]
14. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.
Yamashita H; ten Dijke P; Huylebroeck D; Sampath TK; Andries M; Smith JC; Heldin CH; Miyazono K
J Cell Biol; 1995 Jul; 130(1):217-26. PubMed ID: 7790373
[TBL] [Abstract][Full Text] [Related]
15. Cellular heparan sulfate negatively modulates transforming growth factor-beta1 (TGF-beta1) responsiveness in epithelial cells.
Chen CL; Huang SS; Huang JS
J Biol Chem; 2006 Apr; 281(17):11506-14. PubMed ID: 16492675
[TBL] [Abstract][Full Text] [Related]
16. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
17. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
Fanayan S; Firth SM; Baxter RC
J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
[TBL] [Abstract][Full Text] [Related]
18. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
[TBL] [Abstract][Full Text] [Related]
19. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.
Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Br J Cancer; 2010 Mar; 102(5):844-51. PubMed ID: 20145621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
